These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30928432)

  • 21. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.
    van Dieren S; Kengne AP; Chalmers J; Beulens JW; Davis TM; Fulcher G; Heller SR; Patel A; Colagiuri S; Hamet P; Mancia G; Marre M; Neal B; Williams B; Peelen LM; van der Schouw YT; Woodward M; Zoungas S
    Diabetes Obes Metab; 2014 May; 16(5):426-32. PubMed ID: 24251579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nurse-led psychological intervention for type 2 diabetes: a cluster randomised controlled trial (Diabetes-6 study) in primary care.
    Ismail K; Winkley K; de Zoysa N; Patel A; Heslin M; Graves H; Thomas S; Stringer D; Stahl D; Amiel SA
    Br J Gen Pract; 2018 Aug; 68(673):e531-e540. PubMed ID: 30012812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.
    Chang YL; Sheu WH; Lin SY; Liou WS
    Clin Exp Med; 2018 Aug; 18(3):383-390. PubMed ID: 29572669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-specific impact of major depressive disorder on 12-year change in glycaemic status: Results from a nationwide cohort study of adults without diabetes in Germany.
    Nübel J; Truthmann J; Heidemann C; Du Y; Paprott R; Hapke U; Kruse J; Scheidt-Nave C; Baumert J
    Diabet Med; 2022 Mar; 39(3):e14767. PubMed ID: 34890066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression.
    Brieler JA; Lustman PJ; Scherrer JF; Salas J; Schneider FD
    Fam Pract; 2016 Feb; 33(1):30-6. PubMed ID: 26743722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.
    Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.
    Wilding J; Bailey C; Rigney U; Blak B; Kok M; Emmas C
    Prim Care Diabetes; 2017 Oct; 11(5):437-444. PubMed ID: 28583425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
    Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
    Diabetes Res Clin Pract; 2015 Apr; 108(1):179-86. PubMed ID: 25661664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes.
    Hertroijs DFL; Elissen AMJ; Brouwers MCGJ; Schaper NC; Köhler S; Popa MC; Asteriadis S; Hendriks SH; Bilo HJ; Ruwaard D
    Diabetes Obes Metab; 2018 Mar; 20(3):681-688. PubMed ID: 29095564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
    Bongaerts B; Kuss O; Bonnet F; Chen H; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Khunti K; Medina J; Nicolucci A; Shestakova MV; Watada H; Rathmann W
    Diabetes Obes Metab; 2023 Jul; 25(7):1890-1899. PubMed ID: 36906837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia.
    Rätsep A; Kalda R; Lember M
    Eur J Gen Pract; 2010 Jun; 16(2):85-91. PubMed ID: 20429704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world study.
    Montvida O; Shaw JE; Blonde L; Paul SK
    Diabetes Obes Metab; 2018 Jul; 20(7):1722-1731. PubMed ID: 29536608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).
    Dungan KM; Weitgasser R; Perez Manghi F; Pintilei E; Fahrbach JL; Jiang HH; Shell J; Robertson KE
    Diabetes Obes Metab; 2016 May; 18(5):475-82. PubMed ID: 26799540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme.
    Yeoh E; Png D; Koh PL; Sum CF; Lim SC; Tan HH; Ubeynarayana CU; Subramaniam T
    Diabet Med; 2022 Jan; 39(1):e14733. PubMed ID: 34698420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
    Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
    Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point-of-care testing improves diabetes management in a primary care clinic in South Africa.
    Motta LA; Shephard MDS; Brink J; Lawson S; Rheeder P
    Prim Care Diabetes; 2017 Jun; 11(3):248-253. PubMed ID: 28161128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.